ANTI-HUMAN DLK-1 ANTIBODY HAVING ANTI-TUMOR ACTIVITY IN VIVO

摘要

The present invention provides: an antibody capable of reacting specifically with hDlk-1 and having an anti-tumor activity in vivo (i.e., an anti-hDlk-1 antibody, particularly a humanized antibody); a fragment of the antibody; a hybridoma capable of producing the antibody; a complex of the antibody or a fragment of the antibody and a medicinal agent; a pharmaceutical composition containing the antibody or the like; a therapeutic agent for a tumor; a diagnostic agent for a tumor; an agent for inducing the apoptosis of a tumor cell; a method for treating a tumor; a method for detecting a tumor; a method for inducing the apoptosis of a tumor cell; a kit for detecting and/or diagnosing a tumor; a kit for inducing the apoptosis of a tumor cell; and others.